| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.096 | 0.07 |